Free Trial

Canopy Growth (TSE:WEED) Trading 1.4% Higher - Here's Why

Canopy Growth logo with Medical background

Key Points

  • Canopy Growth Corp's shares increased by 1.4% during mid-day trading, with the last trading price at C$1.48.
  • ATB Capital downgraded their price target for Canopy Growth from C$3.20 to C$1.60, labeling the stock as "underperform."
  • Insider trading was reported, with Director David Angelo Lazzarato selling 15,701 shares at an average price of C$1.68.
  • MarketBeat previews the top five stocks to own by September 1st.

Canopy Growth Corp (TSE:WEED - Get Free Report) shares traded up 1.4% during mid-day trading on Tuesday . The company traded as high as C$1.51 and last traded at C$1.48. 1,172,244 shares changed hands during trading, a decline of 35% from the average session volume of 1,808,395 shares. The stock had previously closed at C$1.46.

Analysts Set New Price Targets

Separately, ATB Capital dropped their price objective on Canopy Growth from C$3.20 to C$1.60 and set an "underperform" rating on the stock in a report on Tuesday, June 3rd.

Check Out Our Latest Report on Canopy Growth

Canopy Growth Trading Up 1.4%

The firm has a 50-day moving average of C$1.73 and a 200-day moving average of C$1.95. The company has a debt-to-equity ratio of 120.38, a quick ratio of 2.32 and a current ratio of 1.39. The firm has a market capitalization of C$238.08 million, a P/E ratio of -0.22, a price-to-earnings-growth ratio of -0.01 and a beta of 1.79.

Insider Transactions at Canopy Growth

In related news, Director David Angelo Lazzarato sold 15,701 shares of the firm's stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of C$1.68, for a total transaction of C$26,307.34. 0.21% of the stock is currently owned by insiders.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines